LOS ANGELES, June, 16, 1998 -- A new molecular marker can be used to better predict tumor progression in men with prostate cancer, the second-leading cause of male cancer deaths in the United States. Researchers at the USC/Norris Comprehensive Cancer Center report the new findings from a study of 96 men with localized disease in the June 17 issue of the Journal of the National Cancer Institute. The team found that patients with tumors expressing abnormally low levels of a protein important in regulating cell division faced a significantly higher risk of disease recurrence and death than patients with tumors expressing high levels of the protein.
The above story is based on materials provided by University Of Southern California. Note: Materials may be edited for content and length.
Cite This Page: